
Cooper Companies (COO) Stock Forecast & Price Target
Cooper Companies (COO) Analyst Ratings
Bulls say
Cooper Companies is a leader in the eyecare industry, with strong market share in both contact lenses and women's health products. The company's robust portfolio of daily and specialty contact lenses, including leading brands like Proclear, Biofinity, MyDay, and Clariti, gives it a competitive edge in the market. Additionally, CooperSurgical, which specializes in reproductive and women's health care, adds diversity to the company's revenue stream. Although there may be some pressure from competitors and ongoing investments, the company's solid financials, ongoing innovations, and potential for upside drivers make it a strong investment opportunity.
Bears say
Cooper Companies is facing headwinds in its CooperSurgical segment due to competition and pricing pressure, which could negatively impact its financial performance. Additionally, there may be a decrease in demand for hormonal IUDs due to concerns about breast cancer risk among women with a family history of PR+ breast cancer. These challenges could result in lower revenue growth and flat operating margins for the company, leading to a negative outlook on its stock. Furthermore, the company's gross margin has already been impacted by tariffs and unfavorable product mix, and while it may see some cost savings from a recent restructuring, it may not be enough to offset these challenges. Therefore, it is important to closely monitor Cooper Companies' financial performance and competitive landscape in the coming quarters to determine whether there may be a need to revise the outlook.
This aggregate rating is based on analysts' research of Cooper Companies and is not a guaranteed prediction by Public.com or investment advice.
Cooper Companies (COO) Analyst Forecast & Price Prediction
Start investing in Cooper Companies (COO)
Order type
Buy in
Order amount
Est. shares
0 shares